Are weight loss drugs really the breakthrough they’re being sold as—or is there a hidden catch?

On this episode of Wellness Unmasked, Dr. Nicole Saphier breaks down two major health stories making headlines—and what they reveal about the state of modern medicine.

First, a meningitis B outbreak in the UK raises serious concerns about vaccine awareness, public health response, and why college students remain at higher risk. Dr. Saphier explains what’s actually happening, why early intervention matters, and what Americans should be watching for next.

Then, a deep dive into the exploding popularity of GLP-1 weight loss drugs like semaglutide and tirzepatide. While these medications are delivering dramatic results, new research shows what happens when patients stop taking them—and it’s not good. From rapid weight regain to declining heart health, the long-term reality may be far more complicated than advertised.

In this episode:

• The truth about meningitis outbreaks and who’s most at risk
• Why vaccine decisions are becoming more individualized
• The real benefits—and risks—of GLP-1 weight loss drugs
• What happens to your body after stopping these medications
• Why sustainable health still comes down to lifestyle, not shortcuts

If you’re trying to make smarter decisions about your health in a world full of quick fixes and conflicting advice, this episode is essential listening.